salbutamol/beclomethasone / Generic mfg. - LARVOL DELTA

Carbon footprint of inhalers in Brazil and Porto Alegre: impacts and alternatives. (PubMed, Cien Saude Colet) - "Data regarding the dispensation of salbutamol and beclomethasone were obtained upon request from the Ministry of Health...The study demonstrated the substantial amount of GreenHouse Gas emissions associated with these devices in Brazil. The substitution with dry powder inhalers or Soft mist inhalers in appropriate situations would prevent significant environmental harm, while also providing clinical benefits to patients, as they are currently the first-line choice recommended by clinical guidelines for the treatment of respiratory diseases."

Journal • Asthma • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Acute bowel ischemia following injection or tirzepatide (EUSEM 2025) - "A 61-year-old female with a history of obesity, hiatus hernia, asthma, osteoarthritis, and hypertension. Her medication included Tirzepatide 2.5mg subcutaneously once weekly, omeprazole 40mg once daily, Atorvastatin 20mg once daily, Salbutamol and Beclomethasone inhalers for Asthma...No underlying thrombosis, embolism, or neoplasia was identified.This case highlights a rare but serious complication associated with tirzepatide, reinforcing the need for vigilance in monitoring its gastrointestinal effects. Given the increasing use of this medication, clinicians must be prepared to recognise and manage rare but potentially life-threatening complications."

Anesthesia • Asthma • Cardiovascular • Gastroenterology • Gastrointestinal Disorder • Genetic Disorders • Hematological Disorders • Hypertension • Immunology • Obesity • Osteoarthritis • Pancreatitis • Respiratory Diseases • Rheumatology • Thrombosis

Access to essential medicines used in the management of noncommunicable diseases in Southern Ethiopia: Analysis using WHO/HAI methodology. (PubMed, SAGE Open Med) - "The top five median price scorers were amlodipine, furosemide, insulin, beclomethasone, and salbutamol. Limited availability suggests the need for better supply chain management and consistent stock availability. The price disparities and affordability challenges identified underscore the necessity for policy interventions such as price regulation and subsidized programs to ensure equitable access to essential noncommunicable disease medications in Arba Minch town, Southern Ethiopia."

Journal • Infectious Disease

PATIENT GROUP EDUCATION SESSIONS: AN EFFECTIVE WAY OF MAKING ASTHMA TREATMENT GREENER? (BTS WM 2023) - "All sessions followed the same format: signing confidentiality forms, brief inhaler-focussed asthma education and inhaler technique demonstrations with Fostair®, beclomethasone or salbutamol DPIs. Regarding symptom control, 3-month post-switch ACT scores remain similar to baseline. Nonetheless, device switch rates suggest group sessions offer a potential strategy for improving sustainability of inhaled asthma treatments."

Clinical • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Costa Rica (ISPOR 2023) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, with 200... In Costa Rica, the total budget impact over three years due to the introduction of Bud-Form as needed was $231,888, less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Panama (ISPOR 2023) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, which have 200... In Panama, the total budget impact over three years due to the introduction of Bud-Form as needed was $381,787, less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Honduras (ISPOR 2023) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, which have 200... In Honduras, the total budget impact over three years due to the introduction of Bud-Form as needed was $342,987, less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Panama (ISPOR 2023) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120, and formoterol has 60... In Panama, the total budget impact over three years due to the introduction of Bud-Form SMART was $1,477,064 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Honduras (ISPOR 2023) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120, and formoterol has 60... In Honduras, the total budget impact over three years due to the introduction of Bud-Form SMART was $1,858,202 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Costa Rica (ISPOR 2023) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120, and formoterol has 60... In Costa Rica, the total budget impact over three years due to the introduction of Bud-Form SMART was $202.653 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Costa Rica (ISPOR-EU 2022) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120 doses, and formoterol has 60 doses... In Costa Rica, the total budget impact over three years due to the introduction of Bud-Form was $202.653 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Panama (ISPOR-EU 2022) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, which have 200... In Panama, the total budget impact over three years due to the introduction of Bud-Form as needed was $381.787 less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Costa Rica (ISPOR-EU 2022) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, which have 200... In Costa Rica, the total budget impact over three years due to the introduction of Bud-Form as needed was $231.888 less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Honduras (ISPOR-EU 2022) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120 doses, and formoterol has 60 doses... In Honduras, the total budget impact over three years due to the introduction of Bud-Form SMART was $1’858.202 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Anti-Inflammatory Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Honduras (ISPOR-EU 2022) - "All inhalers have 120 inhalations, except beclomethasone and salbutamol, which have 200... In Honduras, the total budget impact over three years due to the introduction of Bud-Form as needed was $342.987 less expensive than SoC in patients with mild asthma."

HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Budget Impact of Maintenance and Reliever Therapy With Budesonide-Formoterol Combination in the Treatment of Moderate Asthma in Panama (ISPOR-EU 2022) - "Salbutamol and beclomethasone have 200 doses, Bud-Form has 120 doses, and formoterol has 60 doses... In Panama, the total budget impact over three years due to the introduction of Bud-Form SMART was $1’477.064 less expensive than SoC in patients with moderate asthma."

Clinical • HEOR • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

[VIRTUAL] Late Breaking Abstract - Life cycle assessment (LCA) and cradle-to-grave carbon footprint of a multidose reservoirdry powder inhaler product family (ERS 2021) - "We conducted a full LCA of all six Easyhaler® (EH) products available for treatment of asthma and COPD (budesonide-formoterol; salmeterol-fluticasone; budesonide, beclomethasone, salbutamol, and formoterol EH). Patients with asthma or COPD, and treating physicians alike, are increasingly aware of this. When considering the climate impact of inhalation therapy, DPIs, like EH, have a minimal carbon footprint compared with MDI."

Late-breaking abstract • Asthma • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial (clinicaltrials.gov) - P1; N=81; Recruiting; Sponsor: Sheikh Zayed Medical College

New P1 trial • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

[VIRTUAL] COST-UTILITY OF INHALED CORTICOSTEROIDS IN ADULTS FOR THE TREATMENT OF MILD-TO-MODERATE PERSISTENT ASTHMA IN COLOMBIA (ISPOR 2020) - "METHODS A decision-analysis model was developed to evaluate the cost-effectiveness of budesonide-formoterol (160µg/4.5µg) Maintenance And Reliever Therapy (SMART) versus salmeterol/fluticasone plus salbutamol as needed (SFC) and vs beclomethasone plus salbutamol, a short-acting beta-agonist (SABA), as a standard of care (SoC). CONCLUSIONS : Budesonide-formoterol is a dominant strategy vs SFC+SABA and vs SoC in adult patients with mild-to-moderate asthma in Colombia. SMART allowed more QALYs and was cheaper than SFC+SABA and SoC, this is because budesonide-formoterol has better clinical results than SFC+SABA and SOC and avoided cost because there is fewer exacerbations with SMART."

Clinical • HEOR